Objectives: To confirm three point of care commercial tests for rupture of membranes consistently and accurately detect amniotic fluids from pregnant women, and they are practical and easy to use.
Introduction
Premature rupture of membranes (PROM), defined as spontaneous rupture of membranes (ROM) before the onset of uterine contractions, is one of the most common diagnostic dilemmas in contemporary obstetric practice. Premature rupture of membranes can occur at any gestational age, and preterm PROM (PPROM, defined as PROM before 37 weeks) is responsible for 20-40% of preterm births 1 . Early and accurate diagnosis of PROM would allow for gestational age-specific obstetric interventions designed to optimize perinatal outcome and minimize serious complications such as cord prolapse, preterm delivery, fetal distress and infectious morbidity (chorioamnionitis, neonatal sepsis) 2, 3 . A false-negative result could lead to misdiagnosis and potential fetal demise. Conversely, a falsepositive diagnosis of PROM may lead to unnecessary obstetric interventions, including hospitalization, administration of antibiotics and corticosteroids, and even induction of labour. Therefore, the correct and timely diagnosis of this disorder is of critical importance to the clinician because PROM and PPROM may be associated with serious maternal and neonatal consequences.
The diagnosis of fetal membrane rupture is conventionally made by clinical vaginal examination to observe whether amniotic fluid is leaking from the cervical os. If leaking is absent, subsequent measures to reach a diagnosis include visual inspection of the posterior vaginal fornix for pooling of amniotic fluid, nitrazine/ pH testing of the vaginal fluid and microscopic examination of the fluid for the presence of 'ferning' 4, 5 . Immunoassay tests have become more widely accepted in clinical practice but questions still remain about the specificity and sensitivity of these tests since there is no reliable gold standard to which they may be compared. These immunoassay tests depend on the detection of specific amniotic fluid proteins in vaginal secretions at specified levels that may indicate the membranes have ruptured.
The present study was designed to assess the accuracy of three commercially available tests to detect specific proteins found uniquely in amniotic fluid. [5] [6] [7] Significant concentrations of these proteins are present in amniotic fluid of pregnant women in all trimesters of pregnancy and are used as specific markers for the diagnosis of rupture of the membranes [8] [9] [10] .
The main objective of the study was to assess and compare the capability of the three test kits to consistently and accurately diagnose rupture of the membranes (ROM) in samples of known amniotic fluid. In addition, information was sought regarding which test was preferred by the clinicians in terms of ease of use and convenience.
Methods
Inclusion criteria for the study were healthy pregnant women 16 years and older in which a sample of known amniotic fluid not contaminated with blood was collected during caesarean delivery. Samples that were contaminated with blood were repeated and excluded from the study. Careful collection technique was used to obtain a sample of clear amniotic fluid using a sterile 50cc syringe inserted into the opened amniotic sac at cesarean section. The clinicians who performed the tests were practicing labour and delivery staff members who normally assessed patients for possible ROM. They were all familiar with the methods of performing the tests according to the manufacturers' instructions.
The specimens were individually assessed for positive or negative results using all three test kits and the results recorded on a data form along with a comment survey concerning test kit simplicity, ease of use, and kit preference. Photographs of the three kit results were taken for all testings. Photographs A and B show typical results for specimens taken and tested at the time of sampling. In addition to the actual amniotic fluid (AF) sample testing, particular attention was paid to kit storage and positive and negative control testing.
Following point-of-care testing, each sample was placed in a stabilized preservative tube, refrigerated and subsequently sent to a laboratory for enzyme-linked immunosorbent assay (ELISA) (R and D Systems, 614 McKinley Place NE Minneapolis, MN 55413 USA) which is commercially available with a sensitivity of 31.2 pg/ml for IGFBP-1 and 46 pg/ml for AFP with interassay coefficient of variation of < 10%. The study was approved by the Hospital's Institutional Review Board, and approved for collection and use of the amniotic fluid samples and information for research purposes. Informed consent (and a detailed history) was obtained from all women prior to the caesarean section.
Statistical method and findings
The aim of the statistical analysis was two fold. First, to demonstrate the wide variability of concentrations of proteins used by diagnostic tests to determine rupture of membrane (ROM), using uncontaminated samples of amniotic fluid obtained directly from the placenta during c-section deliveries. Protein concentrations were determined by the ELISA method. Second, compute the sensitivity of three commerical diagnostic tests to detect amniotic fluid in these samples. These tests were Actim TM Prom, AmniSureR and ROM+plus ® . Since all samples were actual amniotic fluid, there should be no negative test results, so all negative results represent false negative conclusions. The assessment of specificity was not possible with this study design, since no samples of fluid other than amniotic fluid was used in the assessment. The standard definition of sensitivity was used, and two-sided 95% confidence intervals for sensitivity were calculated using the Wilson score method. The sensitivity was statistically compared between the three diagnostic tests, two at a time, using a paired sample McNemar test, with no adjustment for multiple comparisons.
Results
During the period from October 2011 to May 2012, 95 women from whom clear amniotic fluid samples were obtained were enrolled into the study. The gestational ages of the pregnancies ranged from 16 to 42 weeks. Concentrations of the samples from the ELISA testing showed IGFPB-1/PAMG-1 levels in the range of 9 to 23688 ng/ml and an AFP range of >10 to 39276 ng/ml. The threshold for the lower limit of detection for the test kits are, respectively, Actim Table 1 ) tested with the Actim TM Prom kit. Furthermore, the ELISA results showed that the protein concentration levels in the fluid samples were all below the upper limits given for the three test kits.
The threshold for lower limit of detection for the kits are as follows: Actim ™ PROM =25ng/ml IGFBP-1, AmniSure ® =5 ng/ml PAMG-1, ROM +plus ® = 5ng/ml IGFBP-1,and 150 ng/ml AFP. As shown in Table 1 and 2, all amniotic fluid samples as analyzed by ELISA were above the threshold except for one sample for www.slcog.lk/sljog The wide variability of proteins in amniotic fluid is presented in frequency table format in Figures 1 and 2 . When the proteins are this variable in amniotic fluid in the placenta, after which the variability is increased in the vagina after ROM due to dilution, contamination, and absorption, this initial variability adds to the difficulty of designing a diagnostic test to detect ROM.
According to the comments submitted on the data collection form by the participants the ROM+plus ® test kit was considered the most convenient and easiest to use and was the preferred kit by all participants due to the shorter collection and preparation time, easier dispensing mechanism of the cassette platform, non-spill buffer vial design and because of the integrated timer.
Discussion
Clinical diagnosis of PROM and PPROM can be difficult or inconclusive in pregnant women who have contradictory signs or symptoms of rupture of the membranes, especially when the gestation is less than 34 weeks 11 . Except when rupture of the membranes is clinically overt (i.e. amniotic fluid is observed escaping directly from the cervical os), biochemical markers are required to help confirm or exclude PROM or PPROM.
The purpose of this study was to assess the efficacy of three commercially available point-of-care immunoassay tests to show a positive result when known amniotic fluid was used. Given that the test samples were all fresh amniotic fluid collected at cesarean section, the expectation was that all three immunoassay tests would have shown a positive reading for the protein in every case. However, in the present study false negative results were recorded with each of the commercial kits tested. Similarly, it Photographs of test results for amniotic fluid samples 62 and 11.
www.slcog.lk/sljog has been reported elsewhere that false positive test results may occur due to the passage of small quantities of amniotic fluid into the vagina through microperforations in the membrane wall 12 or from derivatives of the amniotic proteins produced by decidual cells 13 . With this in mind, the clinician must be aware of the limitations of immunoassay tests when interpreting the results and arrive at a diagnosis as to whether the membranes are ruptured or intact based on an assessment of all relevant clinical findings and not solely on the result of the immunoassay test.
There have been reports of negative AmniSure ® in cases of clinical ROM (false negative results) 14 . It would be important to determine the incidence of failure of these tests to show positive results when known amniotic fluid is being detected. ROM +plus ® demonstrated the least false negative rate. An explanation for these results could be the fact that ROM +plus ® test uses monoclonal and polyclonal antibodies while both actim ™ PROM, and AmniSure ® use only monoclonal antibodies. Polyclonal antibody assays are more sensitive because they can cover the surface of a complex antigen protein more uniformly, thus improving the detection capability. The more binding sites available when the protein flows through the device the better chance that the labeled protein will have something to bind to, showing a more visible line. In addition, monoclonal antibodies can bind to only one type of epitope on the surface of the protein, increasing the possibly of reducing the level of coating. The potential then exists to give up a certain level of sensitivity, and when too much protein is available, the possibility of a hook (prozone) effect increases. Furthermore, the ROM +plus ® detects a second protein, AFP, which may also increase the sensitivity of the test to show a positive line on the test kit.
Conclusion
Amniotic fluid from 94 c-section patients were tested on three different immunoassay tests for the detection of rupture of membranes in order to evaluate the rate of false negatives from the testing. Actim™PROM, AmniSure ® , and ROM +plus ® are available commercially for detection of membrane rupture. ROM +plus ® . Which uses both monoclonal and polyclonal antibodies and two protein detection instead of one proved to be the most accurate and provided the least amount of false negative testing on known samples of amniotic fluid. ROM +plus ® was also rated most simple and easiest to use and detects two different amniotic fluid proteins.
